This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
Sberbank financed the creation of vaccines against coronavirus
Sberbank allocated 176 million rubles for the creation of vaccines and research on the use of drugs for coronavirus. The money collected within the framework of our own charitable program "Stop Coronavirus Together" was transferred to Russian research organizations.
In the spring of this year, the bank's initiative was supported by more than 48 thousand people, including employees and managers of the bank, as well as 127 companies. According to the press service of the bank, following the results of the action, the charitable foundation "Contribution to the Future" received more than 89 million rubles, Sberbank doubled this amount at its own expense.
The collected money allowed us to support six projects of Russian research institutes and organizations to create a vaccine against COVID-19 and drugs for the prevention and treatment of coronavirus, as well as research on the nature of the virus and its consequences for the human body. The total amount left more than 176 million rubles.
The relevance of all funded projects was confirmed by the Russian Ministry of Health. According to the Deputy Chairman of the Board of Sberbank Stanislav Kuznetsov, opening the collection, the bank understood that the common future of the country depends on joint actions - how successfully it will be possible to resist the disease, how quickly vaccines will appear and how effectively COVID-19 can be treated.